Small Cap IR Issues Tenax Therapeutics Analyst Rep
Post# of 297
Posted On: 11/26/2014 9:32:31 AM
Small Cap IR Issues Tenax Therapeutics Analyst Report: Large Validated Market Opportunity Inspires $12 Price Target
| 6:00 AM |
[PR Newswire] - NEW YORK, Nov. 25, 2014 /PRNewswire/ -- Analyst Report by Small Cap IR - Tenax Therapeutics, Inc. (TENX) After a name change and a refocus of priorities the Company is poised to strengthen its position as an emerging providers of products for the critical care market. Tenax Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. The trial is being conducted by Duke University's Duke Clinical Research Institute.
http://us.rd.yahoo.com/finance/news/rss/story...00076.html
~ Press Release! ~
Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html
~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014
| 6:00 AM |
[PR Newswire] - NEW YORK, Nov. 25, 2014 /PRNewswire/ -- Analyst Report by Small Cap IR - Tenax Therapeutics, Inc. (TENX) After a name change and a refocus of priorities the Company is poised to strengthen its position as an emerging providers of products for the critical care market. Tenax Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. The trial is being conducted by Duke University's Duke Clinical Research Institute.
http://us.rd.yahoo.com/finance/news/rss/story...00076.html
~ Press Release! ~
Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html
~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014
(0)
(0)Scroll down for more posts ▼